Article
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Pfizer Recognized as “2024 Corporate Partner of the Year” by American Cancer Society
For more than 20 years, Pfizer has been working to advance breakthroughs in cancer treatment and has pioneered several innovations across multiple types of cancer. But we know our efforts must go beyond the science. Many communities face significant barriers to accessing cancer screening and quality care, and no single organization alone can tackle these challenges. That’s why we partner with patient advocates across the oncology community with the goal of ensuring a more equitable future for...
Chief Corporate Affairs Officer Sally Susman Discusses Political Landscape, AI at Davos
Photo provided by Axios; Photo credit: Dani Ammann PhotographyLast week, nearly 3000 leaders from over 130 countries visited Davos, Switzerland to attend the World Economic Forum’s Annual Meeting. The theme of this year’s meeting was “Collaboration for the Intelligent Age.”Pfizer CEO Albert Bourla was in attendance — he provided his perspective on the future of health for the World Economic Forum and offered a recap of his experience on LinkedIn page — and was joined by Alexandre de Germay...
Five Steps to Prioritize Your Health in 2025
Here at Pfizer, we have a long history of innovation. Over our 176 years (and counting), our doctors and scientists have been at the forefront of some of the most impactful developments in the healthcare field. We aren’t leaving the business of making breakthroughs for our patients anytime soon, but we know that no one is better equipped to manage their own healthcare than our patients themselves.So, as we make our way into 2025, we want to make sure you’re doing what you can to ensure a healthy...
Pfizer and Our CEO Albert Bourla Recognized by TIME, Fortune
2025 is here, but only just barely. Before the new year truly takes hold, we thought we’d take one last look back at 2024.Pfizer strives to not only push the boundaries of what’s achievable in science and medicine, providing access to medicine to as many patients as possible, including those in low-income countries, but also to be an inclusive, enjoyable place to work. We’re proud to have been noticed for those efforts by some leading publications and organizations that highlight companies and...
December Social Media Round-Up—Forbes America’s Dream Employers, ASH and SABCS 2024, and More
Welcome to 2025! We’re excited to look back on our latest social media highlights from December as we plunge headfirst into the new year.CEO Albert Bourla looked to the future by sharing Pfizer’s goals and continued commitment to making a difference in patients’ lives. Our leadership team conveyed a similar message, from reflecting on Pfizer’s contributions to blood disorder and breast cancer research presented at the American Society of Hematology Annual Meeting and the San Antonio Breast...
Pfizer Colleagues Celebrate Native American Heritage
Earlier this year, as part of our efforts to foster diversity within our walls just as strongly as we fight for health access for patients all over the world, Pfizer held an event celebrating the culture of our Indigenous colleagues.Organized by our internal Global Indigenous Community colleague resource group, the “Indigenizing Breakthrough Innovations” cultural celebration was held during Native American Heritage Month.“If you want to be an ally to the native and Indigenous communities in the...
Harnessing the Power of AI to Detect ATTR-CM
Artificial intelligence (AI) has quietly become a part of our daily lives – through personalized recommendations, virtual assistants, or smart devices, we barely notice it anymore. Yet many of us might not realize the advances AI is making in healthcare. From accelerating drug discovery to improving disease detection, it is transforming the way we understand and manage health.AI has had numerous applications in cardiology in recent years, from analyzing results of cardiac imaging tests to...
Pfizer’s Annual DEI Summit Focuses on Inclusion and Connection
Earlier this fall, Pfizer held our annual all-company DEI summit, which was created years ago in an effort to bring colleagues together to discuss important topics around diversity, equity, and inclusion.This year’s Summit, hosted by Chief Global DEI Officer Ramcess Jean-Louis, was themed “Anchor in Trust, Connection Matters” and focused on creating an inclusive environment for all colleagues through representation and building meaningful connections grounded in trust. (Last year’s summit focuse...
November Social Media Round-Up—Access to Medicine Foundation Index, Fortune’s 100 Most Powerful People in Business, and More
The year may be winding down, but Pfizer stayed busy on social media throughout November.CEO Albert Bourla celebrated the company’s fourth place ranking in the 2024 Access to Medicine Foundation Index—moving up two spots from the previous year—while Bourla himself was recognized in Fortune’s inaugural 100 Most Powerful People in Business. The CEO also proudly announced current Chief Oncology Officer Chris Boshoff’s ascension into the role of Chief Scientific Officer and President, R&D effective...
Why Real-World Learnings Matter for People with Breast Cancer
When people understand basic concepts about their health, they’re better able to make more informed decisions. That’s why we are working to improve health literacy, clarify the language that we use around health topics, and return clinical trials data to participants.A breast cancer diagnosis is life-changing; many people facing this diagnosis look to gather as much information about their prognosis and treatment options as possible. We know it’s not enough for us to simply develop breakthrough...
Pfizer Names Dr. Chris Boshoff Chief Scientific Officer
When the company you work for has been advancing breakthroughs for 175 years, there is a lot of scientific talent under one roof.We’re proud to announce that after a comprehensive search, Pfizer’s current Chief Oncology Officer and Executive Vice President, Dr. Chris Boshoff, M.D., Ph.D., has been appointed as Pfizer’s Chief Scientific Officer and President, Research & Development, effective January 1, 2025.Dr. Boshoff was selected after a comprehensive search that kicked off when Dr. Mikael...
Pfizer Works to Address Inequities in IBD Care
Despite advancements in technology that allow for broader reach and easier access to healthcare for people all over the globe, disparities in care remain a challenge, especially for women, diverse populations, and those in more rural areas. As we continue to work towards breakthroughs that change patients’ lives, we recognize that not all breakthroughs are medicine-related; we are also dedicated to improving equity and access for all patients around the world.Recently, we shared a series of...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.